This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07337/identifier/pdb/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07337/identifier/pubchem-compound/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07337/identifier/pubchem-substance/
n9http://linked.opendata.cz/resource/drugbank/drug/DB07337/identifier/drugbank/
n10http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n8http://linked.opendata.cz/resource/drugbank/drug/DB07337/identifier/chemspider/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07337
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB07337 n10:DB07337
dcterms:title
4-[4-AMINO-6-(5-CHLORO-1H-INDOL-4-YLMETHYL)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE
adms:identifier
n8:395302 n9:DB07337 n12:99443808 n13:ABZ n14:448533
n3:IUPAC-Name
n4:271B618F-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B6195-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B6194-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B6191-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B6192-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B6193-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B618D-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B618B-363D-11E5-9242-09173F13E4C5 n4:271B618E-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B618C-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B619B-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B619C-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B6196-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B6197-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B6199-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B6198-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B619A-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B61A1-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B61A3-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B61A4-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B61A0-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B619F-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B61A2-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B6190-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B619D-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B619E-363D-11E5-9242-09173F13E4C5